Literature DB >> 26247370

High-content assay for measuring intracellular growth of Leishmania in human macrophages.

Michael J Dagley1, Eleanor C Saunders1, Kaylene J Simpson2,3, Malcolm J McConville1.   

Abstract

Leishmania species are sandfly-transmitted protozoan parasites that cause a spectrum of diseases, ranging from localized skin lesions to fatal visceral disease, in more than 12 million people worldwide. These parasites primarily target macrophages in their mammalian hosts and proliferate as non-motile amastigotes in the phagolysosomal compartment of these cells. High-throughput screens for measuring Leishmania growth within this intracellular niche are needed to identify host and parasite factors that are required for virulence and to identify new drug candidates. Here we describe the development of a new high-content imaging method for quantifying the intracellular growth of Leishmania mexicana parasites in THP-1 macrophages. Wild-type parasites were pre-stained with the fluorescent dye CellTracker(™) Orange CMRA and used to infect THP-1 macrophages in 384-well plates. Infected and uninfected macrophages were subsequently stained with CellTracker Green CMFDA, allowing accurate quantitation of the number of parasites per macrophage using separate detector channels. We validated this method for use in high-content drug screening by examining the dose dependence of known anti-leishmanial drugs on intracellular growth. Unlike previous protocols, this method does not require the generation of transgenic fluorescent or bioluminescent parasite lines and can be readily adapted for screening different Leishmania species, strains, or mutant lines in a wide range of phagocytic host cell types.

Entities:  

Mesh:

Year:  2015        PMID: 26247370     DOI: 10.1089/adt.2015.652

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  13 in total

1.  Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations.

Authors:  April C Joice; Sihyung Yang; Abdelbasset A Farahat; Heidi Meeds; Mei Feng; Junan Li; David W Boykin; Michael Zhuo Wang; Karl A Werbovetz
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  A Simple Bioluminescent Assay for the Screening of Cytotoxic Molecules Against the Intracellular Form of Leishmania infantum.

Authors:  Diego Benítez; Andrea Medeiros; Cristina Quiroga; Marcelo A Comini
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Paving the Way: Contributions of Big Data to Apicomplexan and Kinetoplastid Research.

Authors:  Robyn S Kent; Emma M Briggs; Beatrice L Colon; Catalina Alvarez; Sara Silva Pereira; Mariana De Niz
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

4.  A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani.

Authors:  Diana Tegazzini; Rosario Díaz; Fernando Aguilar; Imanol Peña; Jesús L Presa; Vanessa Yardley; Julio J Martin; Jose M Coteron; Simon L Croft; Juan Cantizani
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

5.  Development of a semi-automated image-based high-throughput drug screening system.

Authors:  Remzi Onur Eren; Dmitry Kopelyanskiy; Dimitri Moreau; Julien Bortoli Chapalay; Marc Chambon; Gerardo Turcatti; Lon-Fye Lye; Stephen M Beverley; Nicolas Fasel
Journal:  Front Biosci (Elite Ed)       Date:  2018-01-01

6.  Leishmania infantum Induces the Release of sTREM-1 in Visceral Leishmaniasis.

Authors:  Lays G S Bomfim; Lucas S Magalhães; Marcello A A Santos-Filho; Nalu T A Peres; Cristiane B Corrêa; Diego M Tanajura; Angela M Silva; Michael W Lipscomb; Valéria M Borges; Amélia R Jesus; Roque P Almeida; Tatiana R de Moura
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

7.  Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.

Authors:  Diana Ortiz; W Armand Guiguemde; Jared T Hammill; Angela K Carrillo; Yizhe Chen; Michele Connelly; Kayla Stalheim; Carolyn Elya; Alex Johnson; Jaeki Min; Anang Shelat; David C Smithson; Lei Yang; Fangyi Zhu; R Kiplin Guy; Scott M Landfear
Journal:  PLoS Negl Trop Dis       Date:  2017-12-29

8.  Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.

Authors:  Leah S Torrie; Stephen Brand; David A Robinson; Eun Jung Ko; Laste Stojanovski; Frederick R C Simeons; Susan Wyllie; John Thomas; Lucy Ellis; Maria Osuna-Cabello; Ola Epemolu; Andrea Nühs; Jennifer Riley; Lorna MacLean; Sujatha Manthri; Kevin D Read; Ian H Gilbert; Alan H Fairlamb; Manu De Rycker
Journal:  ACS Infect Dis       Date:  2017-10-02       Impact factor: 5.084

9.  sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.

Authors:  Ricardo Luís Louzada Silva; Marcio B Santos; Priscila L S Almeida; Thayse S Barros; Lucas Magalhães; Rodrigo A Cazzaniga; Patrícia R M Souza; Nívea F Luz; Jaqueline França-Costa; Valeria M Borges; Djalma S Lima-Junior; Michael W Lipscomb; Malcolm S Duthie; Steven G Reed; Roque Pacheco Almeida; Amélia Ribeiro Jesus
Journal:  PLoS Negl Trop Dis       Date:  2017-03-29

10.  Development of an automated image analysis protocol for quantification of intracellular forms of Leishmania spp.

Authors:  Ana G Gomes-Alves; André F Maia; Tânia Cruz; Helena Castro; Ana M Tomás
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.